Keyword: Hospira

News

Johnson & Johnson Loses Another Patent Suit

25.01.2018 - US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...

News

Pfizer and Allergan in Merger Talks

30.10.2015 - US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

News

Alvogen to buy Pfizer Drugs for US Market

28.08.2015 - US pharma company Alvogen has agreed to buy four of Pfizer’s products in the USA. The sale is part of Pfizer’s condition in closing its $17 billion acquisition of Hospira. The...

News

Pfizer Gets Green Light for Hospira Acquisition

26.08.2015 - Pfizer can now progress its $17 billion purchase of Hospira after receiving final regulatory approvals from the USA and Brazil. The clearance from the US Federal Trade Commission...

News

EU Approves Pfizer-Hospira Deal With Strings

06.08.2015 - European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...

News

PwC Sees Pharmaceuticals, Life Sciences in M&A Surge

18.05.2015 - The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of...

News

Pfizer Set to Acquire Hospira for $15 Billion

06.02.2015 - Pfizer Set to Acquire Hospira for $15 Billion In its first major deal since the collapse of its effort to buy AstraZeneca last year, US drugmaker Pfizer has announced that it will...